Related Experiment Video

Updated: Aug 14, 2025

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells
08:46

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

Published on: November 12, 2019

53.4K

CAR-T cell engineering with CCR6 exhibits superior anti-solid tumor efficacy

Cheng Zhong1, Jun Chen2

  • 1Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou 510080, China.

Science Bulletin
|January 19, 2023
PubMed
Summary

No abstract available in PubMed .

More Related Videos

Author Spotlight: Advancements in Hypoxia-Sensitive CAR-T Therapy for Enhanced Cancer Immunotherapy09:12

Author Spotlight: Advancements in Hypoxia-Sensitive CAR-T Therapy for Enhanced Cancer Immunotherapy

Published on: June 14, 2024

992
A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

706

Related Concept Videos